Standardization of TSH immunoassays: production of new calibrators and harmonization of assays;Standardisation des immunodosages de la TSH : production de nouveaux calibrateurs et harmonisation des tests

Immuno-Analyse et Biologie Specialisee

Volumn 21, Issue 2, 2006, Pages 79-90

  Donadio, S ^a   Pascual, A ^a   Dugas, M ^a   Ronin, C ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Antigenic polymorphism; Glycosylation; Immunodiagnostic; TSH

Indexed keywords

EPITOPE; HYPOPHYSIS HORMONE; THYROTROPIN;

BLOOD SAMPLING; CALIBRATOR; GLYCOSYLATION; IMMUNOASSAY; IMMUNOCHEMISTRY; MEASUREMENT; PRIORITY JOURNAL; SHORT SURVEY; STANDARDIZATION;

EID: 33747406591     PISSN: 09232532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immbio.2005.09.002     Document Type: Short Survey

References (70)

1. Benkirane M.M., Bon D., Costagliola S., Paolucci F., Darbouret B., Prince P., et al. Monoclonal antibody mapping of the antigenic surface of human thyrotropin and its subunits. Endocrinology 121 3 (1987) 1171-1177
2. Bianucci A.M., and Chiellini F. A 3D model for the human hepatic asialoglycoprotein receptor (ASGP-R). J. Biomol. Struct. Dyn. 18 3 (2000) 435-451
3. Canonne C., Papandreou M.J., Medri G., Verrier B., and Ronin C. Biological and immunochemical characterization of recombinant human thyrotrophin. Glycobiology 5 5 (1995) 473-481
4. Chan B.Y., and Swaminathan R. Analytical and clinical performance of six sensitive thyrotrophin kits. Pathology 22 1 (1990) 11-15
5. Cole E.S., Lee K., Lauziere K., Kelton C., Chappel S., Weintraub B., et al. Recombinant human thyroid stimulating hormone: development of a biotechnology product for detection of metastatic lesions of thyroid carcinoma. Biotechnology (N. Y.) 11 9 (1993) 1014-1024
6. Demers L.M., and Spencer C.A. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Clin. Endocrinol. (Oxf.) 58 2 (2003) 138-140
7. Directive 98/79/EC of the European Parliament and the Council on in vitro iagnostic (IVD) medical devices. October 27 (1998) (Published in the Official Journal of the European Communities, December 7, 1998)
8. Donadio S., Morelle W., Pascual A., Romi-Lebrun R., Michalski J.C., and Ronin C. Both core and terminal glycosylation alter epitope expression in thyrotropin and introduce discordances in hormone measurements. Clin. Chem. Lab. Med. 43 5 (2005) 519-530
9. Drickamer K. Clearing up glycoprotein hormones. Cell 67 6 (1991) 1029-1032
10. Fiete D., Srivastava V., Hindsgaul O., and Baenziger J.U. A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAc beta 1,4GlcNAc beta 1,2Man alpha that mediates rapid clearance of lutropin. Cell 67 6 (1991) 1103-1110
11. Gerngross T.U. Advances in the production of human therapeutic proteins in yeasts and filamentous fungi. Nat. Biotechnol. 22 11 (2004) 1409-1414
12. Grabenhorst E., Schlenke P., Pohl S., Nimtz M., and Conradt H.S. Genetic engineering of recombinant glycoproteins and the glycosylation pathway in mammalian host cells. Glycoconj. J. 16 2 (1999) 81-97
13. Grossmann M., Wong R., Teh N.G., Tropea J.E., East-Palmer J., Weintraub B.D., et al. Expression of biologically active human thyrotropin (hTSH) in a baculovirus system: effect of insect cell glycosylation on hTSH activity in vitro and in vivo. Endocrinology 138 1 (1997) 92-100
14. Haltiwanger R.S., and Hill R.L. The ligand binding specificity and tissue localization of a rat alveolar macrophage lectin. J. Biol. Chem. 261 33 (1986) 15696-15702
15. Helton T.E., and Magner J.A. Sialyltransferase messenger ribonucleic acid increases in thyrotrophs of hypothyroid mice: an in situ hybridization study. Endocrinology 134 6 (1994) 2347-2353
16. Helton T.E., and Magner J.A. Beta-1,4-galactosyltransferase and alpha-mannosidase-II messenger ribonucleic acid levels increase with different kinetics in thyrotrophs of hypothyroid mice. Endocrinology 135 5 (1994) 1980-1985
17. Helton T.E., and Magner J.A. beta-Galactoside alpha-2,3-sialyltransferase messenger RNA increases in thyrotrophs of hypothyroid mice. Thyroid 5 4 (1995) 315-317
18. Hiyama J., Weisshaar G., and Renwick A.G. The asparagine-linked oligosaccharides at individual glycosylation sites in human thyrotrophin. Glycobiology 2 5 (1992) 401-409
19. Hudgin R.L., Pricer Jr. W.E., Ashwell G., Stockert R.J., and Morell A.G. The isolation and properties of a rabbit liver binding protein specific for asialoglycoproteins. J. Biol. Chem. 249 17 (1974) 5536-5543
20. Imperiali B., and O'Connor S.E. Effect of N-linked glycosylation on glycopeptide and glycoprotein structure. Curr. Opin. Chem. Biol. 3 6 (1999) 643-649
21. International Organization for Standardization, and European Committee for Standardization. In vitro diagnostic medical devices--measurement of quantities in samples of biological origin--metrological traceability of values assigned to calibrators and control material. ISO/TC 212/WG2 N65 prEN 17511 (2000), International Organization for Standardization, Geneva, Switzerland
22. Joziasse D.H., Lee R.T., Lee Y.C., Biessen E.A., Schiphorst W.E., Koeleman C.A., et al. alpha3-galactosylated glycoproteins can bind to the hepatic asialoglycoprotein receptor. Eur. J. Biochem. 267 21 (2000) 6501-6508
23. Kashiwai T., Ichihara K., Endo Y., Tamaki H., Amino N., and Miyai K. Immunological and biological characteristics of recombinant human thyrotropin. J. Immunol. Methods 143 1 (1991) 25-30
24. Laurberg P. Persistent problems with the specificity of immunometric TSH assays. Thyroid 3 4 (1993) 279-283
25. Lehrman M.A., Haltiwanger R.S., and Hill R.L. The binding of fucose-containing glycoproteins by hepatic lectins. The binding specificity of the rat liver fucose lectin. J. Biol. Chem. 261 16 (1986) 7426-7432
26. Lequin R.M. Standardization: comparability and traceability of laboratory results. Clin. Chem. 48 2 (2002) 391-393
27. Lisowska E. The role of glycosylation in protein antigenic properties. Cell. Mol. Life Sci. 59 3 (2002) 445-455
28. Magnusson S., and Berg T. Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells. Biochem. J. 291 3 (1993) 749-755
29. Meier M., Bider M.D., Malashkevich V.N., Spiess M., and Burkhard P. Crystal structure of the carbohydrate recognition domain of the H1 subunit of the asialoglycoprotein receptor. J. Mol. Biol. 300 4 (2000) 857-865
30. Miura Y., Perkel V.S., Papenberg K.A., Johnson M.J., and Magner J.A. Concanavalin-A, lentil, and ricin lectin affinity binding characteristics of human thyrotropin: differences in the sialylation of thyrotropin in sera of euthyroid, primary, and central hypothyroid patients. J. Clin. Endocrinol. Metab. 69 5 (1989) 985-995
31. Mizuno Y., Kozutsumi Y., Kawasaki T., and Yamashina I. Isolation and characterization of a mannan-binding protein from rat liver. J. Biol. Chem. 256 9 (1981) 4247-4252
32. Morell A.G., Gregoriadis G., Scheinberg I.H., Hickman J., and Ashwell G. The role of sialic acid in determining the survival of glycoproteins in the circulation. J. Biol. Chem. 246 5 (1971) 1461-1467
33. Müller M.M. Implementation of reference systems in laboratory medicine. Clin. Chem. 46 12 (2000) 1907-1909
34. Papandreou M.J., Sergi I., Benkirane M., and Ronin C. Carbohydrate-dependent epitope mapping of human thyrotropin. Mol. Cell. Endocrinol. 73 1 (1990) 15-26
35. Papandreou M.J., Asteria C., Pettersson K., Ronin C., and Beck-Peccoz P. Concanavalin A affinity chromatography of human serum gonadotropins: evidence for changes of carbohydrate structure in different clinical conditions. J. Clin. Endocrinol. Metab. 76 4 (1993) 1008-1013
36. Papandreou M.J., Persani L., Asteria C., Ronin C., and Beck-Peccoz P. Variable carbohydrate structures of circulating thyrotropin as studied by lectin affinity chromatography in different clinical conditions. J. Clin. Endocrinol. Metab. 77 2 (1993) 393-398
37. Persani L., Borgato S., Romoli R., Asteria C., Pizzocaro A., and Beck-Peccoz P. Changes in the degree of sialylation of carbohydrate chains modify the biological properties of circulating thyrotropin isoforms in various physiological and pathological states. J. Clin. Endocrinol. Metab. 83 7 (1998) 2486-2492
38. Pierce J.G., and Parsons T.F. Glycoprotein hormones: structure and function. Annu. Rev. Biochem. 50 (1981) 465-495
39. Pontow S.E., Kery V., and Stahl P.D. Mannose receptor. Int. Rev. Cytol. 137B (1992) 221-244
40. Price A., Burgin C., Catch I., and Cruise M. Functional sensitivity and recovery of thyroid-stimulating hormone. Clin. Chem. 47 11 (2001) 2067
41. Pricer Jr. W.E., and Ashwell G. The binding of desialylated glycoproteins by plasma membranes of rat liver. J. Biol. Chem. 246 15 (1971) 4825-4833
42. Pricer Jr. W.E., Hudgin R.L., Ashwell G., Stockert R.J., and Morell A.G. A membrane receptor protein for asialoglycoproteins. Methods Enzymol. 34 (1974) 688-691
43. Prieels J.P., Pizzo S.V., Glasgow L.R., Paulson J.C., and Hill R.L. Hepatic receptor that specifically binds oligosaccharides containing fucosyl alpha1 leads to 3 N-acetylglucosamine linkages. Proc. Natl. Acad. Sci. USA 75 5 (1978) 2215-2219
44. Qasba P.K. Involvement of sugars in protein-protein interactions. Carbohydrates Polymers. 41 (2000) 293-309
45. Rafferty B., and Gaines Das R. > Comparison of pituitary and recombinant human thyroid-stimulating hormone (rhTSH) in a multicenter collaborative study: establishment of the first World Health Organization reference reagent for rhTSH. Clin. Chem. 45 12 (1999) 2207-2215
46. Rasmussen A.K., Hilsted L., Perrild H., Christiansen E., Siersbaek-Nielsen K., and Feldt-Rasmussen U. Discrepancies between thyrotropin (TSH) measurement by four sensitive immunometric assays. Clin. Chim. Acta 259 1-2 (1997) 117-128
47. Rawlins M.L., and Roberts W.L. Performance characteristics of six third-generation assays for thyroid-stimulating hormone. Clin. Chem. 50 12 (2004) 2338-2344
48. Ribela M.T., Bianco A.C., and Bartolini P. The use of recombinant human thyrotropin produced by Chinese hamster ovary cells for the preparation of immunoassay reagents. J. Clin. Endocrinol. Metab. 81 1 (1996) 249-256
49. Ronin C., Papandreou M.J., Sergi S., Labbe-Jullie C., Medri G., Hoffmann T., et al. Glycosylation-dependent epitope mapping of human TSH (hTSH) isoforms. Int. J. Rad. Appl. Instrum. B 17 7 (1990) 651-656
50. Schaaf L., Trojan J., Helton T.E., Usadel K.H., and Magner J.A. Serum thyrotropin (TSH) heterogeneity in euthyroid subjects and patients with subclinical hypothyroidism: the core fucose content of TSH-releasing hormone-released TSH is altered, but not the net charge of TSH. J. Endocrinol. 144 3 (1995) 561-571
51. Schaaf L., Theodoropoulou M., Gregori A., Leiprecht A., Trojan J., Klostermeier J., et al. Thyrotropin-releasing hormone time-dependently influences thyrotropin microheterogeneity--an in vivo study in euthyroidism. J. Endocrinol. 166 1 (2000) 137-143
52. Schlesinger P.H., Rodman J.S., Doebber T.W., Stahl P.D., Lee Y.C., Stowell C.P., et al. The role of extra-hepatic tissues in the receptor-mediated plasma clearance of glycoproteins terminated by mannose or N-acetylglucosamine. Biochem. J. 192 2 (1980) 597-606
53. Seitz O. Glycopeptide synthesis and the effects of glycosylation on protein structure and activity. ChemBioChem 1 4 (2000) 214-246
54. Sergi I., Papandreou M.J., Medri G., Canonne C., Verrier B., and Ronin C. Immunoreactive and bioactive isoforms of human thyrotropin. Endocrinology 128 6 (1991) 3259-3268
55. Sergi I., Medri G., Papandreou M.J., Gunz G., Jaquet P., and Ronin C. Polymorphism of thyrotropin and alpha subunit in human pituitary adenomas. J. Endocrinol. Invest. 16 1 (1993) 45-55
56. Smedsrod B., Melkko J., Risteli L., and Risteli J. Circulating C-terminal propeptide of type I procollagen is cleared mainly via the mannose receptor in liver endothelial cells. Biochem. J. 271 2 (1990) 345-350
57. Spencer C.A., Takeuchi M., Kazarosyan M., MacKenzie F., Beckett G.J., and Wilkinson E. Interlaboratory/intermethod differences in functional sensitivity of immunometric assays of thyrotropin (TSH) and impact on reliability of measurement of subnormal concentrations of TSH. Clin. Chem. 41 3 (1995) 367-374
58. Stenman U.H. Immunoassay standardization: is it possible, who is responsible, who is capable?. Clin. Chem. 47 5 (2001) 815-820
59. Szkudlinski M.W., Thotakura N.R., Bucci I., Joshi L.R., Tsai A., East-Palmer J., et al. Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells: the role of sialylation and sulfation in TSH bioactivity. Endocrinology 133 4 (1993) 1490-1503
60. Szkudlinski M.W., Thotakura N.R., Tropea J.E., Grossmann M., and Weintraub B.D. Asparagine-linked oligosaccharide structures determine clearance and organ distribution of pituitary and recombinant thyrotropin. Endocrinology 136 8 (1995) 3325-3330
61. Szkudlinski M.W., Thotakura N.R., and Weintraub B.D. Subunit-specific functions of N-linked oligosaccharides in human thyrotropin: role of terminal residues of alpha- and beta-subunit oligosaccharides in metabolic clearance and bioactivity. Proc. Natl. Acad. Sci. USA 92 20 (1995) 9062-9066
62. Thotakura N.R., Desai R.K., Bates L.G., Cole E.S., Pratt B.M., and Weintraub B.D. Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells. Endocrinology 128 1 (1991) 341-348
63. Tietz N.W. Accuracy in clinical chemistry--does anybody care?. Clin. Chem. 40 6 (1994) 859-861
64. Townsend R., and Stahl P. Isolation and characterization of a mannose/N-acetylglucosamine/fucose-binding protein from rat liver. Biochem. J. 194 1 (1981) 209-214
65. Trojan J., Theodoropoulou M., Usadel K.H., Stalla G.K., and Schaaf L. Modulation of human thyrotropin oligosaccharide structures--enhanced proportion of sialylated and terminally galactosylated serum thyrotropin isoforms in subclinical and overt primary hypothyroidism. J. Endocrinol. 158 3 (1998) 359-365
66. Van Hall E.V., Vaitukaitis J.L., Ross G.T., Hickman J.W., and Ashwell G. Effects of progressive desialylation on the rate of disappearance of immunoreactive HCG from plasma in rats. Endocrinology 89 1 (1971) 11-15
67. Vliegenthart J.F. Intramolecular carbohydrate-protein interaction. Adv. Exp. Med. Biol. 491 (2001) 133-140
68. Wood W.G., Waller D., and Hantke U. An evaluation of six solid-phase thyrotropin (TSH) kits. J. Clin. Chem. Clin. Biochem. 23 8 (1985) 461-471
69. Wood W.G., Bruns U., Eber O., Langsteger W., Bounaud J.Y., and Bounaud M.P. Evaluation of the Abbott IMx ultrasensitive II hTSH immunometric assay in three European centres: a comparison with established commercial immunometric assays for thyrotropin. Eur. J. Clin. Chem. Clin. Biochem. 34 2 (1996) 151-158
70. Zerfaoui M., and Ronin C. Glycosylation is the structural basis for changes in polymorphism and immunoreactivity of pituitary glycoprotein hormones. Eur. J. Clin. Chem. Clin. Biochem. 34 9 (1996) 749-753